Abstract
The study of neuroscience has vastly benefited from the use of brain slices. This preparation has been fundamental for the understanding of the cellular basis of nervous system function as well as for the study of the mechanisms involved in neuronal network dysfunction. This experimental model provides flexible access, and control of, specific neural circuits and maintains their basic properties, allowing them to reproduce most of their natural network activities. Brain slices permit the combination of sophisticated techniques such as electrophysiology, fluorescence imaging, pharmacology, molecular biology, etc. More recently, the development of organotypic brain slice cultures has expanded the use of modern technical approaches to the study neuronal networks, while increasing their possibilities of evaluating long-term effects of acute experimental conditions, as well as the effects of chronic treatments on neuronal network function in vitro. Here, I will provide an overview of the use of organotypic cultures to understand neuronal network function and dysfunction, as well as the pharmacological approaches used for these studies. As a final example, I will review the studies performed in organotypic cultures regarding the deleterious effects of long-term amyloid beta application on neuronal networks in vitro, as well as the use of drugs that may prevent or revert their deleterious effects on nervous system function. Overall, this review will provide elements to support the use of organotypic cultures as a very reliable model to explore long-term neuropharmacological studies in vitro.
Keywords: Organotypic Cultures, Brain slices, Nervous System, electrophysiology, fluorescence imaging, neuronal network
Current Medicinal Chemistry
Title: Organotypic Cultures as Tool to Test Long-Term Effects of Chemicals on the Nervous System
Volume: 17 Issue: 10
Author(s): F. Pena
Affiliation:
Keywords: Organotypic Cultures, Brain slices, Nervous System, electrophysiology, fluorescence imaging, neuronal network
Abstract: The study of neuroscience has vastly benefited from the use of brain slices. This preparation has been fundamental for the understanding of the cellular basis of nervous system function as well as for the study of the mechanisms involved in neuronal network dysfunction. This experimental model provides flexible access, and control of, specific neural circuits and maintains their basic properties, allowing them to reproduce most of their natural network activities. Brain slices permit the combination of sophisticated techniques such as electrophysiology, fluorescence imaging, pharmacology, molecular biology, etc. More recently, the development of organotypic brain slice cultures has expanded the use of modern technical approaches to the study neuronal networks, while increasing their possibilities of evaluating long-term effects of acute experimental conditions, as well as the effects of chronic treatments on neuronal network function in vitro. Here, I will provide an overview of the use of organotypic cultures to understand neuronal network function and dysfunction, as well as the pharmacological approaches used for these studies. As a final example, I will review the studies performed in organotypic cultures regarding the deleterious effects of long-term amyloid beta application on neuronal networks in vitro, as well as the use of drugs that may prevent or revert their deleterious effects on nervous system function. Overall, this review will provide elements to support the use of organotypic cultures as a very reliable model to explore long-term neuropharmacological studies in vitro.
Export Options
About this article
Cite this article as:
Pena F., Organotypic Cultures as Tool to Test Long-Term Effects of Chemicals on the Nervous System, Current Medicinal Chemistry 2010; 17 (10) . https://dx.doi.org/10.2174/092986710790820679
DOI https://dx.doi.org/10.2174/092986710790820679 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research Structure, Biological Properties and Applications of Marine-derived Polysaccharides
Current Organic Chemistry Recent Progress in Research on Ribosome Inactivating Proteins
Current Protein & Peptide Science The IL-12 Family of Cytokines in Infection, Inflammation and Autoimmune Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Diabetes, Cognitive Function, and the Blood-Brain Barrier
Current Pharmaceutical Design Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) Heterocycles in the Treatment of Neglected Tropical Diseases
Current Medicinal Chemistry Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Pharmacological Modulation of the State of Awareness in Patients with Disorders of Consciousness: An Overview
Current Pharmaceutical Design Viral-Mediated Gene Transfer for Cancer Treatment
Current Pharmaceutical Biotechnology Amygdalar Atrophy in Early Alzheimer’s Disease
Current Alzheimer Research Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Management of COVID-19 very Elderly Patients in Nursing Homes and Long-Term Care Facilities: Description of a New Model and Experience in a Medicalized Nursing Home
Coronaviruses Mosquito and Tick-borne Illnesses in the United States. Guidelines for the Recognition and Empiric Treatment of Zoonotic Diseases in the Wilderness.
Infectious Disorders - Drug Targets Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)
Current Pharmaceutical Design Anti-NMDA Receptor Encephalitis in Psychiatry
Current Psychiatry Reviews Bridge Between Neuroimmunity and Traumatic Brain Injury
Current Pharmaceutical Design